AI-generated summary
The authors reviewed medical records of 44 patients with head and neck cancer treated with radiation therapy or chemoradiation, comparing 22 who received photobiomodulation with 22 controls. The authors report that photobiomodulation was associated with lower maximum mucositis grades, with a median of 1 versus 3. They state that photobiomodulation may have a role in reducing treatment complications, mainly mucositis severity.
- Participants
- 44
- Who or what was studied
- Patients with head and neck cancer treated with radiation therapy or chemoradiation therapy, 2015 to 2021 (22 receiving photobiomodulation, 22 controls; median age 63.5 years)
- Limits stated in the abstract
- This was a retrospective medical record review with a small sample and no randomization, so the authors' comparison cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Control group, GRADE, Confidence interval. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.